Erasca, Inc. ERAS
NASDAQ · United States · Health Technology
$14.59-0.07 (-0.48%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.14 | -0.11 | -25.7% | $0 | — | +2.5%$18.12→$18.58 |
| Q1 2026 | 2026-05-11 | -0.60 | -0.23 | -160.9% | — | — | +2.6%$10.12→$10.38 |
| Q4 2025 | 2026-03-12 | -0.10 | -0.11 | +9.1% | — | — | -12.1%$15.50→$13.62 |
| Q3 2025 | 2025-11-12 | -0.11 | -0.11 | 0.0% | — | — | +7.6%$2.36→$2.54 |
| Q2 2025 | 2025-08-12 | -0.12 | -0.11 | -9.1% | — | — | — |
| Q1 2025 | 2025-05-13 | -0.11 | -0.13 | +15.4% | — | — | — |
| Q4 2024 | 2025-03-20 | -0.11 | -0.13 | +15.4% | — | — | — |
| Q3 2024 | 2024-11-12 | -0.11 | -0.17 | +35.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.